About
Our Name
Mission
Values
Leadership
Board of Directors
Science
Therapeutic Focus
Pipeline
Palmoplantar pustulosis (PPP)
Familial Mediterranean fever (FMF)
Behcet’s disease
Hidradenitis suppurativa (HS)
Scientific Publications
Clinical Trials
For Patients
Investors
Partnerships
Newsroom
Press Releases
In the News
Events
Contact
About
Our Name
Mission
Values
Leadership
Board of Directors
Science
Therapeutic Focus
Pipeline
Palmoplantar pustulosis (PPP)
Familial Mediterranean fever (FMF)
Behcet’s disease
Hidradenitis suppurativa (HS)
Scientific Publications
Clinical Trials
For Patients
Investors
Partnerships
Newsroom
Press Releases
In the News
Events
Contact
PRESS RELEASE
Aristea Therapeutics Strengthens its Board of Directors with the Appointment of Three Accomplished Biopharma Leaders From Poseida Therapeutics, Novo Holdings and Pfizer
August 24, 2022
2022 © Copyright. Aristea Therapeutics. All Rights Reserved.